Exact Sciences Corporation (EXAS) Stock Analysis

Abbott closes $23 billion deal to buy Madison-based Exact Sciences

Tue, March 24, 2026 at 10:05 AM UTC 4 min read

Abbott has finalized a $23 billion acquisition of Exact Sciences, a Madison-based company known for its cancer screening technologies. This strategic move aims to enhance Abbott's portfolio in the diagnostics sector, potentially driving future growth and innovation. For investors, this acquisition could signal increased market competitiveness and expanded revenue streams for Abbott, while also impacting Exact Sciences' stock performance as it integrates into a larger healthcare entity.

Read full article →

Abbott acquisition of Exact Sciences set to close on March 23, 2026

Fri, March 20, 2026 at 1:00 PM UTC 4 min read

Abbott's acquisition of Exact Sciences is scheduled to close on March 23, 2026. This strategic move is significant for investors as it could enhance Abbott's portfolio in the diagnostics sector, potentially driving growth and innovation. The acquisition may also impact Exact Sciences' stock performance, as investors assess the long-term benefits of the merger in the competitive healthcare market.

Read full article →